Immunovant, Inc. ( IMVT) - Stock Earnings
IMVT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -110.6 million USD | — USD |
| 2026Q1 | -147.9 million USD | — USD |
| 2026Q2 | -153.2 million USD | 7.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
IMVT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -259.3 million USD | — USD |
| 2025 | -413.8 million USD | — USD |
| 2026 | -505.6 million USD | — USD |
| 2026 Est. | — | — |
IMVT
Price: $41.82
52 week price:
Earnings Per Share: -2.93 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 791496
Market Capitalization: 8.8 billion